87 related articles for article (PubMed ID: 488408)
21. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
[TBL] [Abstract][Full Text] [Related]
22. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
Mroueh AM; Siler-Khodr TM
J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
[TBL] [Abstract][Full Text] [Related]
23. The treatment of hyperprolactinemia with a new ergot derivative, lergotrile mesylate.
Sherman BM; Swanson JA; Chapler FK
Fertil Steril; 1978 Mar; 29(3):291-5. PubMed ID: 565303
[TBL] [Abstract][Full Text] [Related]
24. [Metergoline in hyperprolactinemic breast cancer: a phase II study].
Holtkamp W; Nagel GA
Onkologie; 1986 Oct; 9(5):245-8. PubMed ID: 3101016
[TBL] [Abstract][Full Text] [Related]
25. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG
Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349
[TBL] [Abstract][Full Text] [Related]
26. [Lisuride in the treatment of sterility and amenorrhoea induced by elevated prolactin levels (author's transl)].
Marek J; Zivný J; Srámková J; Kobilková J
Cesk Gynekol; 1981 Sep; 46(8):593-600. PubMed ID: 7307108
[No Abstract] [Full Text] [Related]
27. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
[No Abstract] [Full Text] [Related]
28. Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinemic patients.
Bennink HJ
Fertil Steril; 1979 Mar; 31(3):267-72. PubMed ID: 571359
[TBL] [Abstract][Full Text] [Related]
29. Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected pituitary tumors.
Mornex R; Orgiazzi J; Hugues B; Gagnaire JC; Claustrat B
J Clin Endocrinol Metab; 1978 Aug; 47(2):290-5. PubMed ID: 400717
[TBL] [Abstract][Full Text] [Related]
30. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
Netter A; Netter AL; Gorins A
Gynecologie; 1975; 26(2):141-5. PubMed ID: 1164955
[No Abstract] [Full Text] [Related]
31. Dynamic evaluation of prolactin secretion in patients with oligospermia: effects of treatment with metergoline.
Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
Fertil Steril; 1979 Jan; 31(1):63-7. PubMed ID: 105938
[TBL] [Abstract][Full Text] [Related]
32. The effect of lisuride hydrogen maleate in the hyperprolactinaemia-amenorrhoea syndrome: clinical and hormonal responses.
De Cecco L; Foglia G; Ragni N; Rossato P; Venturini PL
Clin Endocrinol (Oxf); 1978 Dec; 9(6):491-8. PubMed ID: 106990
[TBL] [Abstract][Full Text] [Related]
33. [Methergoline in the treatment of prolactinemia in women].
Radowicki S
Ginekol Pol; 1983; 54(11-12):729-35. PubMed ID: 6368327
[No Abstract] [Full Text] [Related]
34. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
Dickey RP; Stone SC
Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
[TBL] [Abstract][Full Text] [Related]
35. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
Boyd AE; Reighlin S
N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
[No Abstract] [Full Text] [Related]
36. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).
McIntosh EN
J Clin Endocrinol Metab; 1976 Jun; 42(6):1192-5. PubMed ID: 945301
[TBL] [Abstract][Full Text] [Related]
37. Metergoline as an inhibitor of prolactin release.
Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
[TBL] [Abstract][Full Text] [Related]
38. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
Frantz AG; Kleinberg DL
Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
[TBL] [Abstract][Full Text] [Related]
39. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
Schellekens LA; Roland R; Lequin RM
Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
[No Abstract] [Full Text] [Related]
40. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
